Pfizer, BioNTech Agree to Produce COVID-19 Vaccine for Africa

Pfizer and BioNTech have reached an agreement with a South African company to produce their COVID-19 vaccine for distribution in Africa, the biotechnology companies said Wednesday.

The Biovac Institute in Cape Town will manufacture 100 million doses of the vaccine annually starting in 2022. The company will mix vaccine ingredients it receives from Europe, place them in vials and package them for distribution to the 54 countries in Africa.

The agreement may eventually help alleviate vaccine shortages on a continent where the Africa Centers for Disease Control and Prevention says less than 2% of its population of 1.3 billion has received at least one dose.

Pfizer CEO Albert Bourla said the company’s goal is to provide people throughout Africa with the vaccine, a departure from previous bilateral agreements that saw most doses being sold to wealthy countries.

The Johnson & Johnson vaccine is already being manufactured in South Africa in a similar “fill and finish” process that has the capacity to produce more than 200 million doses annually. The vaccines are also being distributed across the African continent.

Source: Voice of America

COVID-19 Surging in Africa, WHO Warns

NAIROBI – The World Health Organization has warned that COVID-19 is gaining ground in Africa, with the death toll jumping 43% in the past week. WHO says the continent recorded 1 million new cases in just one month, with several countries facing shortages of oxygen and beds for patients.

Speaking during a virtual press briefing Thursday, Matshidiso Moeti, WHO regional director, said Africa is recording its highest number of COVID-19 cases since the virus hit the continent in early 2020.

“Over the past month, Africa recorded an additional 1 million cases,” Moeti said. “This is the shortest time it has taken so far to add one1 million cases. Comparatively, it took around three months to move from 4 million to 5 million cases. This COVID-19 resurgence is the fastest the continent has seen.”

The global health agency says 12 African countries are experiencing an upward trend of coronavirus, including Algeria, Malawi, Senegal and Zimbabwe.

Moeti says the number of Africans losing lives to the virus is high.

“As this surge sweeps across Africa, we are witnessing a brutal cost, and life-lost deaths have climbed steeply for the past five weeks, jumping 40 percent in the past week,” Moeti said. “This is a clear warning our hospitals are at a breaking point. In all, 153,000 people have sadly died. Africa is just 1 percent shy of the peak in fatalities reached in January.”

The increase in deaths is partly blamed on the delta coronavirus variant that medical experts say is the most transmittable of all the variants. It has been reported in 21 African countries.

Namibia is one African country where the total number of COVID-19 positives is on the decline. However, more than 1,000 people have died there from COVID-19 in the last month.

Ismail Katjitae is a physician at the Ministry of Health and Social Services in Namibia. He explains why the death rate is so high.

“A high prevalence of comorbidities in some communities, limited capacity in some districts and regions to manage severe and critical cases,” Katjitae said. “And a strong misinformation lobby resulting in noncompliance with public health measures, underutilizing available health care services, and delayed complicated presentation in our health facilities.”

So far, only 18 million people out of the 1.3 billion living in Africa have been vaccinated. Some African countries blame the slow vaccination process on the shortage of vaccine doses in the global market.

Catherine Kyobutungi is the head of the African Population and Health Research Center. She says African governments should ask their citizens to follow health protocols like washing hands and wearing masks to limit the spread of the virus.

“Other than the usual measures, Africa does not have too many options without really having much of its population vaccinated,” Kyobutungi said. “So, the hope is that in the next month around August, many countries will receive at least substantial doses of the Johnson and Johnson vaccine, but before then, keeping in place the usual measures.”

Most African countries have eased health measures meant to combat the spread of the virus for economic reasons, and failure to follow those measures is blamed for the spread.

Some African countries expect to get hundreds of thousands of vaccines in the coming weeks as the Aspen pharmaceutical company in South Africa begins producing 400 million vaccines.

Source: Voice of America

Malawi’s Survey Confirms AstraZeneca Vaccine Efficacy

BLANTYRE – In Malawi, a survey by the Ministry of Health to help ascertain the efficacy of AstraZeneca vaccine has shown its effectiveness in fighting the coronavirus. The survey was based on current hospital admissions of COVID-19 patients across the country.

The preliminary results of the findings released Saturday were based on COVID-19 admissions between June 26 and July 8 of this year.

These results show that over 80% of 227 COVID-19 patients admitted during the period were those not vaccinated.

And those who have only had one AstraZeneca jab were 12% while those fully vaccinated only accounted for 4%.

The secretary of the Ministry of Health, Dr. Charles Mwansambo, says it’s still too early to measure the effectiveness of the AstraZeneca vaccine based on these findings.

“We are still vaccinating more and presently our vaccination status is still low. But what we have found out so far is that the majority of those that are coming in those that are not vaccinated,” he said.

However, he says the findings would help end fears and doubts some Malawians had over the vaccine, which prevented them from getting vaccinated.

Malawi has currently vaccinated about 400,000 people of the 11 million needed to reach herd immunity.

“So we encourage more people to come for vaccination because obviously this is strongly putting a case for vaccination. So I encourage citizens to make sure that they come for vaccination,” said Mwansambo.

In May, Malawi destroyed about 20,000 doses of AstraZeneca vaccine which had expired.

The incineration was largely because many Malawians were reluctant to be vaccinated over concerns on the vaccine’s safety and efficacy.

Lydia Kamwana, a baker in Blantyre, said the survey is a wake-up call to her.

“I haven’t been vaccinated,” she said. “I really wanted to go for the jab but then I was so scared. And when I saw those findings, the results are making sense and I am convinced I will get the jab once the vaccine is in stock.”

Maziko Matemba is the national community ambassador for health in Malawi. He welcomes the survey findings but he says the government is now responsible to ensure it has enough vaccine for its people.

“As you know, this is one or less than one percent of the population which has been vaccinated. So the bigger population is not well vaccinated,” he said.

However, Mwansambo said Malawi is expected to receive a donation of 192,000 doses of AstraZeneca vaccines Thursday to restock its vaccination centers, which ran out of vaccine mid-June.

Source: Voice of America

Court Orders Ugandan Government to Regulate COVID-19 Treatment Costs

KAMPALA, UGANDA – Edward Bindhe was diagnosed in early June with COVID-19. Upon consultation with a doctor, he bought drugs off the shelf and stocked up on local herbs.

Then, with a collapsed lung, failed breathing and total body weakness, Bindhe, who had just lost two relatives to COVID-19, was admitted to a private hospital.

Bindhe, who is continuing to receive treatment as an outpatient, said that while in the ward, a cashier constantly visited his bed reminding him of his accumulating medical bill.

“After two days of admission, the hospital told me they needed me to advance some money, 2.5 [million shillings or $750], and I did not have it anyway,” he said. “That’s when I was then transferred to the COVID ward. Thereafter, on 29th, like, I started getting better. And the doctor said, ‘No, now we can discharge you.’ So, at discharging me, that’s when they gave me a medical bill of 8.8 [million shillings, or $2,482].”

Overcharging patients, early dismissals

Through June, local media was awash with reports of hospitals overcharging patients, pushing some families to abandon deceased loved ones in hospitals, while some patients were released from hospitals for failure to pay their bills.

It is for those reasons that Moses Mulumba, the head of the Center for Health, Human Rights and Development, a health advocacy organization, petitioned the High Court in Kampala on June 28, seeking intervention.

The court ruled Thursday that Health Minister Jane Ruth Aceng and the attorney general must intervene by making regulations for reasonable fees payable to hospitals for management and treatment of COVID-19 patients.

The court also ordered the Uganda medical and dental practitioners council to make recommendations to the minister of health regarding reasonable fees chargeable by hospitals for treatment and management of persons suffering from COVID-19.

Mulumba said he was happy they got a consent judgment.

“The government has been watching the pandemic for over a year. And it has done all the steps,” he said. “But many of these steps are toward making sure the individual is contained, the individual is held accountable. And it was a very simple ask: that when it comes to a pandemic like COVID-19, the minister should invoke her powers under the public health legislation to actually regulate the actors. Because we believe that the actors are part of the national response. And if they are part of the national response, they need to look at themselves not just as businesspeople.”

The few Ugandans who were ladmitted to public health centers offering free treatment still faced other challenges.

Irene Nakasita spent three weeks in a referral hospital in Jinja after she failed to get admitted at the Mulago National Hospital, where she was told there were no beds left.

Now, back in a private hospital to deal with the side effects of COVID-19 drugs administered to her at the public hospital, Nakasita said that while the government can intervene in the affairs of private hospitals, they need to improve services in the public facilities to save Ugandans from heavy bills.

‘Pay the doctors’

“I know how I suffered,” she said. “So, let government fix issues in the government facilities so that people are comfortable to go there and get medicine. And then also pay the doctors. Because partly why I suffered in Jinja, some of those doctors were complaining they were not paid and now their lives are being risked to attend to COVID patients. They never attended to us — they left us in the hands of nurses.”

Attorney General Kiryowa Kiwanuka said the court order would be followed.

“We are going to advise the Ministry of Health to comply with the order of court,” Kiwanuka said. “And the Ministry of Health and the medical council need to meet and engage with the medical practitioners and get back to court with the compliance.”

At a government news conference last week, the head of the Uganda health care federation said 45 percent of patient bills are driven by personal protective equipment, oxygen and medication.

Source: Voice of America

UNICEF to Ship 220 Million Doses of J&J COVID-19 Vaccine to African Union

UNICEF said Thursday it has signed a deal to provide up to 220 million doses of the Johnson & Johnson COVID-19 vaccine to African Union member states by the end of 2022.

The child humanitarian group announced in a statement the agreement was reached with Belgium-based and J&J-owned Janssen Pharmaceutica NV.

An additional 35 million doses of the single-dose vaccine could be delivered to the African Union’s 55-member states by the end of this year and another 180 million doses could be ordered by year’s end, UNICEF said.

“African countries must have affordable and equitable access to COVID-19 vaccines as soon as possible. Vaccine access has been unequal and unfair, with less than 1 per cent of the population of the African continent currently vaccinated against COVID-19. This cannot continue,” said UNICEF Executive Director Henrietta Fore. “UNICEF, with its long history of delivering vaccines all around the world, is supporting global COVID-19 vaccination efforts through AVAT, COVAX, and other channels to maximize supply and access to vaccines.”

The J&J vaccine received emergency approval from the World Health Organization in March.

Source: Voice of America

WHO Calls for Urgent Action to Slow COVID-19 Spread in Africa

GENEVA – The World Health Organization is calling for urgent action to stem the rapid spread of COVID-19 across Africa, which is being fueled by a surge of more contagious variants of the disease.

Latest reports say COVID-19 cases in Africa have been rising by 25% every week for the past six weeks, bringing reported cases there to more than 5.4 million, including 141,000 deaths.

WHO regional director for Africa, Matshidiso Moeti, warns the rampant spread of the more contagious alpha, beta, and delta variants is raising the pandemic threat across the continent to a new level.

“The speed and scale of Africa’s third wave is like nothing we have seen before,” said Moeti. “Cases are doubling every three weeks, compared to every four weeks at the start of the second wave. Almost 202,000 cases were reported in the past week and the continent is on the verge of exceeding its worst week ever in this pandemic.”

In the same period, WHO reports deaths have risen by 15% across 38 African countries to nearly 3,000. The jump is largely due to the highly transmissible coronavirus variants, which have spread to dozens of countries. The most contagious delta variant has been found in 16 countries. It reportedly has become the dominant strain in South Africa.

Moeti says more people are falling ill and requiring hospitalization, even people younger than 45 years. She says evidence is growing that the delta variant is causing longer and more severe illness.

With Africa’s lack of life-saving vaccines, Moeti says it is important for people to practice public health measures, such as wearing masks, social distancing, and frequent handwashing to prevent the disease from spreading.

“With WHO’s guidance, countries are taking action to curb the rise in cases,” said Moeti. “All countries in resurgence in the region have put limits on people gathering to help with physical distancing. …They are using nuanced, risk-based approaches, informed by the local epidemiology, in an effort to avoid nationwide lockdowns that we know cause great harm to livelihoods, particularly for low-income households.”

Vaccines are proving highly effective against the COVID-19 variants and in ending devastating surges of severe cases of the disease. They are widely available in the world’s richest countries, but not Africa.

Moeti is urgently appealing to countries to share their excess doses to help plug the continent’s vaccine gap, saying Africa must not be left languishing in the throes of its worst wave yet.

Source: Voice of America

South African Firm to Produce COVID-19 Vaccine for African Countries

NAIROBI, KENYA – The South African pharmaceutical company Aspen has begun production of hundreds of millions of doses of COVID-19 vaccine for African countries. To speed up the process, the company is getting a large funding boost from the U.S. government.

Speaking during a virtual press briefing Thursday, Mark Marchick, a top executive for the U.S. International Development Financial Corporation, said Aspen would receive about $712 million to produce vaccine for people in Africa.

“Our consortium of development financing institutions would provide a direct loan to Aspen, among other things, to strengthen their balance sheet with long-term financing, support vaccine production and expand their operations with core operations based in South Africa. This loan will help them increase capacity to support Aspen’s effort to produce vaccines for the continent this year and next year,” Marchik said.

Gayle Smith, the U.S. State Department coordinator for the global COVID-19 response, said the investment will help Africa deal with long-term health issues.

“We see this investment as in the short-term a really viable response to the urgent need on the continent for vaccines for COVID and also, importantly, as a long-term investment in the capacity of the continent to increase its own production of this vital goods so there is a greater availability and resilience over time, so it’s a short-term investment with a long-term vision,” Smith said.

It is estimated that the world needs at least 11 billion COVID-19 vaccine doses to at least help communities return to normal lives. So far, less than 2% of Africans have received a vaccine.

The need for vaccine has prompted criminals to exploit Africa’s weak regulatory systems to bring in phony and substandard drugs.

In November, officers from South Africa’s customs and crime unit seized 2,400 fake COVID-19 vaccine doses. Zambian and Chinese nationals were arrested.

In January of this year Nigeria’s food and drug administration advised the public to be aware of nefarious players pushing phony vaccines.

Adebayo Alonge, head of RxAll, an organization that fights counterfeit and substandard pharmaceuticals in Africa using artificial intelligence technology, said African governments need systems to efficiently distribute and keep track of the vaccine.

“They can have selected sites across the country where people can go and be vaccinated. People pre-book online or by SMS and make a record of those people who have come and taken the vaccine at those locations,” Alonge said.

Aspen, which is based in the city of Durban, is slated to produce 400 million doses of the Johnson and Johnson vaccine. Distribution will begin in the next few weeks.

Source: Voice of America

WHO Says Africa Facing Third COVID Wave, Driven by Variants

The World Health Organization (WHO) warned Thursday that the African continent is facing a surging third wave of COVID-19 cases, driven by new and faster variants of the coronavirus that causes it.

During a virtual briefing, WHO Regional Director for Africa Dr. Matshidiso Moeti said new cases have increased by an average of 25 percent in Africa for six straight weeks, to almost 202,000 in the week ending on June 27. She said deaths rose by 15 percent across 38 African countries to nearly 3,000 in the same period.

Moeti said this wave is being driven by more contagious COVID-19 variants, “raising the threat to Africa to a whole new level.” She said among the 14 African countries now in resurgence, 12 have detected variants of concern, including nine with the Delta variant, originally identified in India.

Meanwhile, she said the Alpha and Beta variants have been reported in 32 and 27 countries respectively.

Moeti said hygiene, social distancing and mask wearing can certainly help slow the spread, but globally, it has been shown that vaccines offer the best path toward ending devastating surges.

Just over 1% of Africans are now fully vaccinated, compared to 11% of people globally, and over 46% of people in the United States and Britain.

Earlier Thursday, in interviews with the Associated Press, African Union Vaccine Envoy Strive Masiyiwa blasted Europe and international suppliers for failing to deliver promised vaccine.

Masiyiwa said that while Europe has promised to sell vaccines to Africa, so far, it has not followed through. He said, “The fact of the matter is the EU has vaccine factories. It has vaccine production centers across Europe. Not a single dose, not one vial has left a European factory for Africa.”

African CDC Director John Nkengasong said the WHO-managed international vaccine cooperative COVAX had promised to deliver 700 million vaccine doses to Africa by December. But to date, Africa has received just 65 million doses overall and fewer than 50 million doses have arrived through COVAX.

However, both leaders did announce that the first shipments of the single-shot Johnson & Johnson and the Pfizer-BioNTech vaccines, with U.S. support, will begin arriving next week.

Source: Voice of America